Portrait of Theodoric Chew
Photo: Courtesy of St. Gallen Symposium · Publisher-directed editorial display; source copyright retained

FigureAsia 35 Under 35 · Healthcare

Theodoric Chew

Age 30 · Mental-health services and digital care delivery · Singapore

A Singaporean founder whose platform reports service availability in more than 150 countries and over 40 languages, backed by a growing clinical workforce.

Approximate age at 31 December 2025
30
Field
Healthcare
Country or region
Singapore
FigureAsia U35 Assessment
89.5 / 100

Career and documented record

Theodoric Chew's achievement is operational rather than speculative: assembling a mental-health service that can work across languages, employer programmes, self-guided support and clinician-led care. By 2025, company materials and a public-market programme dossier described availability in more than 150 countries, over 40 languages, a workforce of roughly 250 and reach measured in millions of lives. Earlier reporting placed usage above three million people.

Those figures are not a substitute for audited clinical outcomes. They do, however, document a scale of access that is rare for a company founded in Southeast Asia, particularly in a field constrained by stigma, clinician supply and fragmented purchasing. Chew's personal agency is direct: he began the company after his own experience with anxiety, built the founding product and has remained the accountable chief executive through regional and global expansion.

The editorial case rests on what the platform has made structurally possible — multilingual entry points, employer-financed access and stepped levels of support — rather than a claim that an app alone treats every condition. Quality, escalation and jurisdiction-specific clinical governance remain the decisive tests as the organization grows.

Why Theodoric Chew is on the list

FigureAsia selected Chew because he has built one of the most internationally distributed healthcare services to emerge from Singapore under a founder still below 35. The platform's reach is consequential even after discounting organization-reported metrics, and its multilingual design speaks directly to Asia's diversity. His score is moderated by limited public, independently audited outcome data; the ranking recognizes delivery infrastructure and access, not a claim of universal therapeutic effectiveness.

The 2025–26 record

Principal milestone

Service availability reported in more than 150 countries

Evidence record

More than 40 supported languages

Scale or implementation

Earlier public reporting placed reach above three million people

The work in its field

Within mental-health services and digital care delivery, the relevant test is whether a result can survive scrutiny of maturity, attribution, validity and practical fit. That distinction matters: completed evidence is not projected benefit, and individual responsibility is not interchangeable with the wider team’s achievement.

Assessment breakdown

89.5out of 100

01

Substantive 2025–2026 contribution

18 / 20

The score reflects completed 2025–26 work in mental-health services and digital care delivery, assessed at the documented maturity of deployed multinational mental-health service.

02

Verified impact

13.5 / 15

Impact credit is limited to the measured study, regulatory, implementation or operating record stated in the profile; unsupported patient benefit is excluded.

03

Originality and distinction

8 / 10

The work creates or materially advances a distinctive capability within mental-health services and digital care delivery rather than relying on title or institutional association.

04

Field and industry influence

9 / 10

The assessment recognises demonstrated effects on research, product development, care delivery or professional practice, with publicity alone carrying no weight.

05

Individual agency

10 / 10

Named authorship and the documented role of Cofounder and Chief Executive Officer establish individual responsibility while preserving credit for collaborators.

06

Durability and trajectory

4.5 / 5

The cited work forms part of a continuing programme, platform or research trajectory rather than a single uncompleted announcement.

07

Asian significance and global relevance

5 / 5

The Asian connection is material to the person's identity, operating base or populations served: Singaporean founder building an Asia-based mental-health platform with international reach.

08

Clinical and scientific validity

4.9 / 7

Clinical and scientific validity is calibrated to deployed multinational mental-health service, with the profile retaining the evidence boundary attached to the result.

09

Safety, quality and responsible governance

5.6 / 7

Safety and governance credit reflects accurate regulatory language, study limitations, data stewardship and the refusal to turn early evidence into clinical certainty.

10

Translation and care-pathway fit

6 / 6

The work is scored for its demonstrated fit with a laboratory, regulatory, clinical, operational or public-health pathway, not for projected future adoption.

11

Access, equity and resource stewardship

5 / 5

Access credit reflects documented reach, capacity, affordability or inclusion while distinguishing service volume from proven clinical outcome.

Evidence and attribution

Material claims on this page are supported by the edition’s evidence record. FigureAsia tests age, identity, role, result and individual attribution before publication. Public profiles present the reported record; supporting documentation is retained for accuracy review and corrections.

Achievement records
4
Assessment window
2025–26
Editorial status
Included in the 2026 FigureAsia 35 Under 35 edition

Rights and credit

The portrait is published under the rights basis recorded for this edition. Third-party ownership and reuse restrictions remain in force.

Publication status
Published under a documented rights basis
Credit
Courtesy of St. Gallen Symposium
Licence
Publisher-directed editorial display; source copyright retained
Portrait source and credit